Remus Pharmaceuticals Limited (NSE: REMUS)
India flag India · Delayed Price · Currency is INR
2,359.20
-50.30 (-2.09%)
At close: Dec 24, 2024

Remus Pharmaceuticals Company Description

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceutical finished formulations and products in India and internationally.

It is involved in trading of active pharmaceutical ingredient, as well as provides technical consultancy services to various distributors and contract manufacturing services.

The company offers capsule, cream, eye drop, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablets.

It has operations in Bhutan, Bolivia, Chile, Costa Rica, Cuba, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong Kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, and Vietnam.

The company was formerly known as Remus Pharmaceuticals Private Limited and changed its name to Remus Pharmaceuticals Limited in January 2023.

Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.

Remus Pharmaceuticals Limited
Country India
Founded 2015
Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Employees 48
CEO Arpit Shah

Contact Details

Address:
1101 to 1103, South Tower
Ahmedabad, Gujarat 380054
India
Phone 91 79 2999 9857
Website remuspharma.com

Stock Details

Ticker Symbol REMUS
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
SIC Code 5122

Key Executives

Name Position
Arpit Shah Chief Executive Officer
Anjali Shah Chief Financial Officer